Hideki Nagao insider trades: Medicinova (MNOV) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Hideki reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 28, 2022 | MNOV | ↓ Sell | 6,754 | $2.25 | $15K | Direct | Nov 30, 2022 (2d) |
| Nov 22, 2022 | MNOV | ↓ Sell | 5,583 | $2.18 | $12K | Direct | Nov 23, 2022 (1d) |
| Nov 17, 2022 | MNOV | ↓ Sell | 309 | $2.18 | $674 | Direct | Nov 21, 2022 (4d) |
| Mar 11, 2021 | MNOV | ↓ Sell | 2,354 | $7.40 | $17K | Direct | Mar 15, 2021 (4d) |
| Sep 15, 2020 | MNOV | ↓ Sell | 1,000 | $5.78 | $6K | Direct | Sep 16, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MNOV insiders
Open-market trades in the last 12 months
About Hideki Nagao's insider trades
Hideki Nagao is a director at Medicinova (MNOV). Since Sep 15, 2020, Hideki has reported no open-market purchases and 5 sales worth $51K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNOV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.